Sterigenics International LLC, a global provider of contract sterilization, gamma technologies and medical isotopes, has acquired Nelson Laboratories, Inc., a large U.S. provider of life-cycle microbiology testing services for the medical devices, pharmaceutical and tissue industries. Financial terms were not disclosed.
 
Nelson Labs has 570 employees, including more than 300 scientists and 60 registered and specialist microbiologists, and runs 85 labs out of five corporate buildings in Salt Lake City, UT.
 
All Nelson Labs operations will remain in Salt Lake City and will be combined with Sterigenics’ existing microbiological and analytical testing and consultancy, SteriPro Labs. The combined companies under the Nelson Labs brand will operate as a standalone business unit within Sterigenics International.  Jeffery Nelson will serve as president of Nelson Labs.
 
“This is a significant strategic acquisition to help build out Sterigenics’ lab testing and service capabilities on a global scale, enabling us to better serve our multinational customers,” said Michael Mulhern, chief executive officer of Sterigenics International.  “We will continue to explore additional expansion opportunities for our lab services to meet our customers’ growing needs.”
  
“Sterigenics will be a great partner, and will provide the global access and ongoing investment necessary to ensure long-term growth of the lab services business,” said Mr. Nelson. “They are a global leader in contract sterilization and sterility assurance serving the same markets as Nelson Labs. This is an excellent cultural fit, and I’m excited for the opportunities this will bring for our teams and our customers throughout the world.”